Cargando…

Design and profile of low-molecular-weight receptor tyrosine kinase inhibitors for antiangiogenic therapy

Detalles Bibliográficos
Autor principal:	Wood, JM
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2001
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300586/ http://dx.doi.org/10.1186/bcr403

Ejemplares similares

Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple Myeloma
por: Ribatti, Domenico
Publicado: (2010)

The assessment of side effects of tyrosine kinase inhibitors (TKI) applied in patients with advanced thyroid cancer (TC) - one centre experience
por: Krajewska, Jolanta, et al.
Publicado: (2013)

Pulsatile high-dose treatment with antiangiogenic tyrosine kinase inhibitors improves clinical antitumor activity
por: Rovithi, Maria, et al.
Publicado: (2017)

Radioprotective and tumor antiangiogenic effect of the novel synthetic superoxide dismutase (SOD) mimetic compounds
por: Vujaskovic, Z, et al.
Publicado: (2001)

OPCML, a novel systems regulator of tyrosine kinase signaling in ovarian and other cancers
por: Gabra, H
Publicado: (2012)

Low-molecular-weight heparin-coated cardiopulmonary bypass: coagulatory and clinical findings
por: Mirow, N, et al.
Publicado: (2001)

B cell antigen receptor-induced plasma membrane recruitment of the SH2 domain-containing inositol phosphatase is mediated by the protein tyrosine kinases Lyn and Syk
por: Engelke, M, et al.
Publicado: (2009)

Effect of unfractionated and low molecular weight heparin on microcirculatory antithrombin effects during endotoxemia
por: Hoffmann, JN, et al.
Publicado: (2002)

The Outcome of Discontinuing Tyrosine Kinase Inhibitors in Advanced Sarcoma Following a Favorable Tumor Response to Antiangiogenics Therapy
por: Zhang, Zhusheng, et al.
Publicado: (2022)

PERK Inhibition by HC-5404 Sensitizes Renal Cell Carcinoma Tumor Models to Antiangiogenic Tyrosine Kinase Inhibitors
por: Stokes, Michael E., et al.
Publicado: (2023)

Wheezing in low birth weight infants
por: Wandalsen, Gustavo Falbo, et al.
Publicado: (2015)

Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model
por: Diaz, Roque, et al.
Publicado: (2010)

Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?
por: Roviello, Giandomenico, et al.
Publicado: (2021)

Case of Tracheoesophageal Fistula Formation as a Rare Complication of Antiangiogenic Tyrosine Kinase Inhibitor Therapy for Metastatic Hepatocellular Carcinoma
por: Adeoye, Oluwatayo, et al.
Publicado: (2023)

Nutrition of very low birth-weight infants
por: De Curtis, Mario, et al.
Publicado: (2014)

Minerals and extremely low birth weight infants
por: Salvatori, Guglielmo, et al.
Publicado: (2015)

Hypothyroxinemia in extremely low birth weight infants
por: Ghirri, Paolo, et al.
Publicado: (2015)

Relationship between peak anti-Xa levels and calculated creatinine clearance in ICU patients receiving low molecular weight heparin
por: McDonald, E, et al.
Publicado: (2003)

Hypoglycemia and hyperglycemia in extremely low-birth-weight infants
por: De Carolis, Maria Pia, et al.
Publicado: (2015)

The angiogenic properties of Kaposi's sarcoma-associated herpesvirus encoded G-protein coupled receptor are reduced by flavopiridol, an inhibitor of cyclin-dependent kinase 9
por: McFerrin, Harris, et al.
Publicado: (2010)

Preoperative aspirin continuation versus replacement therapy with low molecular weight heparin before coronary surgery: effects on postoperative bleeding risk
por: Spadaccio, Cristiano, et al.
Publicado: (2015)

Vitamins and functional nutrients for extremely low birth weight infants
por: Salvia, Gennaro, et al.
Publicado: (2015)

Antiangiogenic tyrosine kinase inhibition related gastrointestinal perforations: a case report and literature review
por: Walraven, Maudy, et al.
Publicado: (2010)

BrainView: a software designed for quantifying brain volume, weight and density
por: Lescot, T, et al.
Publicado: (2003)

Trophic feeding for very preterm or very low birth weight infants
por: Civardi, Elisa, et al.
Publicado: (2015)

Receptor Tyrosine Kinases and Inhibitors in Lung Cancer
por: Pisick, Evan, et al.
Publicado: (2004)

Recurrent respiratory infections in the follow-up of the extremely low birth weight infant
por: Sacco, Oliviero, et al.
Publicado: (2015)

The immunoglobulin tail tyrosine of membrane-bound IgG and IgE provides antigen receptor-intrinsic costimulation to class-switched memory B cells
por: Engels, N, et al.
Publicado: (2009)

Characterization of acquired receptor tyrosine–kinase fusions as mechanisms of resistance to EGFR tyrosine–kinase inhibitors
por: Xu, Haiyuan, et al.
Publicado: (2019)

Effect of tyrosine ingestion on cognitive function and load carriage performance in the heat
por: Coull, Nicole, et al.
Publicado: (2015)

Molecular Basis of Drug Resistance: Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Anaplastic Lymphoma Kinase Inhibitors
por: Yang, Sei-Hoon
Publicado: (2013)

Delivery room management of extremely low birth weight infants in Italian level III hospitals
por: Trevisanuto, Daniele, et al.
Publicado: (2015)

Epidermal growth factor receptor tyrosine kinase inhibitors
por: Ranson, M
Publicado: (2004)

Should serum creatinine kinase levels and an ECG be routinely obtained in low voltage electrical burn injuries?
por: Pallett, JR, et al.
Publicado: (2013)

Transfer of protease inhibitors to inhibit cartilage destruction
por: van der Laan, WH, et al.
Publicado: (2001)

Proteinase-activated receptors 1 and 2 activate protein kinase D1 in human melanoma cells
por: Kempkes, C, et al.
Publicado: (2009)

Quantitative Tyrosine Phosphoproteome Profiling of AXL Receptor Tyrosine Kinase Signaling Network
por: Wu, Xinyan, et al.
Publicado: (2021)

XMRV: usage of receptors and potential co-receptors
por: Setty, Mohan K H G, et al.
Publicado: (2011)

Identification and characterization of small molecular NPR-B receptor antagonists
por: Andresen, Henriette, et al.
Publicado: (2015)

Efficacy of SGLT2 inhibitors in glycemic control, weight loss and blood pressure reduction: a systematic review and meta-analysis
por: Pinto, Lana Catani, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_91hcbe5odad6dvrhfp0kfb89l1